연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1491. Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution.
Kim K, Chie EK, Park HJ, Kim DG, Jung HW, Park SH, Kim IH.
Clin Transl Oncol 2014 Sep;16(9):829-33
Link
1490. Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients.
Koh Y1, Lee SY, Kim I, Kwon JH, Yoon SS, Park S, Chung MH, Suh SY, Kim KS, Kim HS.
Cancer Chemother Pharmacol. 2014 Sep;74(3):653-7. doi: 10.1007/s00280-014-2555-0. Epub 2014 Aug 6.
Link
1489. Enhanced cytotoxic effect of radiation and
temozolomide in malignant glioma cells:
targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases
Eun Jung Choi1†, Bong Jun Cho1†, David J Lee1†, Yeo Hyeon Hwang1†, Sun Ha Chun1, Hans H Kim1
and In Ah Kim1,2
BMC Cancer. 2014 Jan 13;14:17. doi: 10.1186/1471-2407-14-17.
Link
1488. Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.
Keam B, Ha H, Kim TM, Jeon YK, Lee SH, Kim DW, Kim CW, Heo DS.
Leuk Lymphoma. 2015 Jan 21:1-7. [Epub ahead of print]
Link
1487. Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Keam B1, Kim DW1, Park JH2, Lee JO2, Kim TM1, Lee SH1, Chung DH3, Heo DS1.
Cancer Res Treat. 2014 Oct;46(4):323-30. doi: 10.4143/crt.2013.120. Epub 2014 Jul 14.
Link
1486. The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.
Sim SH1, Keam B, Kim DW, Kim TM, Lee SH, Chung DH, Heo DS.
J Cancer Res Clin Oncol. 2014 Dec;140(12):2135-42. doi: 10.1007/s00432-014-1768-2. Epub 2014 Jul 9.
Link
1485. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer.
Go SI1, Keam B2, Kim TM3, Lee SH3, Kim DW3, Kim HJ4, Wu HG4, Chung DH5, Heo DS3.
Clin Lung Cancer. 2014 Mar;15(2):e1-6. doi: 10.1016/j.cllc.2013.09.003. Epub 2013 Nov 14.
Link
1484. Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer.
Keam B1, Kim DW, Park JH, Lee JO, Kim TM, Lee SH, Chung DH, Heo DS.
Int J Clin Oncol. 2014 Aug;19(4):594-600. doi: 10.1007/s10147-013-0602-1. Epub 2013 Aug 6.
Link
1483. A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.
Kim DW, Oh DY, Shin SH, Kang JH, Cho BC, Chung JS, Kim H, Park KU, Kwon JH, Han JY, Kim MJ, Bang YJ1.
BMC Cancer. 2014 Nov 3;14:795. doi: 10.1186/1471-2407-14-795.
Link
1482. The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study.
Shin DY1, Kim DW2, Keam B3, Kim TM3, Lee SH3, Kang CH4, Kim YT4, Heo DS3
Lung Cancer. 2014 Aug;85(2):320-5. doi: 10.1016/j.lungcan.2014.05.021. Epub 2014 Jun 4.
Link